| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/10/2011 | US20110034398 Use of imp3 as a prognostic marker for cancer |
| 02/10/2011 | US20110034397 Intestinal immune system stimulator |
| 02/10/2011 | US20110034396 Methods and compositions for inhibiting cell migration and treatment of inflammatory conditions |
| 02/10/2011 | US20110034395 Compositions and methods of inhibiting apoptosis |
| 02/10/2011 | US20110034394 Composition comprising protein and disperse fat |
| 02/10/2011 | US20110034393 Use of a novel natural agent in cosmetic compositions |
| 02/10/2011 | US20110034392 Hyaluronic Acid and Chondroitin Sulfate Based Hydrolyzed Collagen Type II and Method of Making Same |
| 02/10/2011 | US20110034391 Shaped article |
| 02/10/2011 | US20110034390 Peptides, compositions, and uses thereof |
| 02/10/2011 | US20110034389 Active agents, compositions, and methods for inhibiting and reversing platelet function |
| 02/10/2011 | US20110034388 Collagen and fibrin microthreads in a discrete thread model of in vitro acl scaffold regeneration |
| 02/10/2011 | US20110034387 Polypeptide inhibiting angiogenesis and application thereof |
| 02/10/2011 | US20110034386 Dendroaspis natriuretic peptide for treatment of cancer |
| 02/10/2011 | US20110034385 Compositions Useful for the Treatment of Diabetes and Other Chronic Disorder |
| 02/10/2011 | US20110034384 COMBINATION VEGFR2 THERAPY WITH mTOR INHIBITORS |
| 02/10/2011 | US20110034383 Cxcl12 gamma a chemokine and uses thereof |
| 02/10/2011 | US20110034382 Use of liver growth factor (lgf) as a neural tissue regenerator |
| 02/10/2011 | US20110034381 Methods for Therapeutic Treatment of Benign Prostatic Hypertrophy (BPH) |
| 02/10/2011 | US20110034380 Combination of a selective ppar-gamma modulator and an incretin for the treatment of diabetes and obesity |
| 02/10/2011 | US20110034379 Gastrin Compositions And Formulations, And Methods Of Use And Preparation |
| 02/10/2011 | US20110034378 Pharmaceutical Combinations Comprising Specified Age Breaker and Further Drugs, I.A. Antihypertensive Drugs, Antidiabetic Drugs Etc. |
| 02/10/2011 | US20110034377 Exendin and Exendin Agonists for Eating Disorders |
| 02/10/2011 | US20110034376 Use of Lipid-Rich Nutrition for the Treatment of Post-Operative Ileus |
| 02/10/2011 | US20110034375 Non-basic melanin concentrating hormone receptor-1 antagonists |
| 02/10/2011 | US20110034374 Oxyntomodulin for Preventing or Treating Excess Weight |
| 02/10/2011 | US20110034373 Use of an fgf-21 compound and a glp-1 compound for the treatment of obesity |
| 02/10/2011 | US20110034372 Truncated activin type ii receptor and methods of use |
| 02/10/2011 | US20110034371 L. casei rhamnosus secreted factors and use thereof |
| 02/10/2011 | US20110034370 Bis-met histones |
| 02/10/2011 | US20110034369 Agonists of Bitter Taste Receptors and Uses Thereof |
| 02/10/2011 | US20110034368 Multiple Gene Expression Including sORF Constructs and Methods with Polyproteins, Pro-Proteins and Proteolysis |
| 02/10/2011 | US20110033852 Present invention relates to methods for prediction of the therapeutic success of breast cancer therapy |
| 02/10/2011 | US20110033560 Preparation and a component intended to be added to a tobacco product |
| 02/10/2011 | US20110033551 Nucleic acid microspheres, production and delivery thereof |
| 02/10/2011 | US20110033549 Stabilisation of Proteins |
| 02/10/2011 | US20110033548 Degradable crosslinked aminated dextran microspheres and methods of use |
| 02/10/2011 | US20110033547 Dehydrated chitosan nanoparticles |
| 02/10/2011 | US20110033543 Hydrogels with covalent and noncovalent crosslinks |
| 02/10/2011 | US20110033535 Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
| 02/10/2011 | US20110033527 Opthalmic compositions of cyclosporin |
| 02/10/2011 | US20110033526 Pharmaceutical composition of antibiotics and prebiotics for preventing and treating dysbiosis during antibacterial therapy |
| 02/10/2011 | US20110033525 Diterpene Glycosides as Natural Solubilizers |
| 02/10/2011 | US20110033524 Treatment of tumors |
| 02/10/2011 | US20110033521 Molecules and Methods of Using Same for Treating MCP-1/CCR2 Associated Diseases |
| 02/10/2011 | US20110033518 Peptides promoting lipid efflux via abca1 and activating a lipoprotein lipase |
| 02/10/2011 | US20110033517 Coatings for implantable medical devices comprising hydrophilic substances and methods for fabricating the same |
| 02/10/2011 | US20110033516 Methods and compositions for bone healing by periostin |
| 02/10/2011 | US20110033507 Polypeptides KXK and Their Use |
| 02/10/2011 | US20110033503 Dressing compositions and methods |
| 02/10/2011 | US20110033499 Anti-viral nutraceutical |
| 02/10/2011 | US20110033494 Anti-Infective Agents and Uses Thereof |
| 02/10/2011 | US20110033492 Vaccines for brucellosis |
| 02/10/2011 | US20110033490 Compositions and methods for diagnosing and/or treating influenza infection |
| 02/10/2011 | US20110033488 Agents and methods for treatment of anxiety disorders |
| 02/10/2011 | US20110033487 Vaccines and diagnostics for the ehrlichioses |
| 02/10/2011 | US20110033480 Methods and compositions involving nucleotide repeat disorders |
| 02/10/2011 | US20110033470 Human G-Protein Coupled Receptor |
| 02/10/2011 | US20110033469 Leukotriene b4 binding soluble lipocalin receptor from ixodes ricinus |
| 02/10/2011 | US20110033468 Ophthalmic Drug Delivery System Containing Phospholipid and Cholesterol |
| 02/10/2011 | US20110033463 Apheresis, administration of agent, or combination thereof |
| 02/10/2011 | US20110033461 Combination Therapy for the Treatment of Cancer |
| 02/10/2011 | US20110033459 Combination therapy with a compound acting as a platelet adp receptor inhibitor |
| 02/10/2011 | US20110033457 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
| 02/10/2011 | US20110033451 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor |
| 02/10/2011 | US20110033448 Inhibitors of LL-37 Mediated Immune Reactivity to Self Nucleic Acids |
| 02/10/2011 | US20110033444 Genetic variants in a hypertension susceptibility gene Stk39 and uses thereof |
| 02/10/2011 | US20110033443 Method for Increasing Bone Mass |
| 02/10/2011 | US20110033441 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 02/10/2011 | US20110033440 Novel process for solubilizing protein from a proteinaceous material and compositions thereof |
| 02/10/2011 | US20110033439 Targeted antimicrobials and related compositions, methods and systems |
| 02/10/2011 | US20110033438 Method and pharmacological composition for the diagnosis and treatment of male |
| 02/10/2011 | US20110033437 Debridement Method Using Topical Nitric Oxide Donor Devices and Compositions |
| 02/10/2011 | US20110033422 Treatments for flaviviridae virus infection |
| 02/10/2011 | US20110033421 Methods related to immunostimulatory nucleic acid-induced interferon |
| 02/10/2011 | US20110033420 Macrocyclic compounds as hepatitis c virus inhibitors |
| 02/10/2011 | US20110033419 Methods and Compositions for Treating Cancer |
| 02/10/2011 | US20110033418 Treatment of diseases caused by viral infection |
| 02/10/2011 | US20110033417 2,3-substituted indole derivatives for treating viral infections |
| 02/10/2011 | US20110033416 RNA Vaccines |
| 02/10/2011 | US20110033415 Agent for differentiating hematopoietic stem cell into natural killer cell comprising yc-1 or il-2 1 and a method of differentiating hematopoietic stem cell into natural killer cell using the same |
| 02/10/2011 | US20110033414 Cardiovascular therapy composition including transfer factor and therapeutic methods including use of the composition |
| 02/10/2011 | US20110033402 Solubilized benzoyl small molecule |
| 02/10/2011 | US20110033392 Deodorizing composition under weak acidity |
| 02/10/2011 | US20110033391 Transferases and Oxidoreductases, Nucleic Acids Encoding them and methods for making and using them |
| 02/10/2011 | US20110033384 Chimeric polypeptides and their use |
| 02/10/2011 | DE10164805B4 Verfahren und Mittel zur Modifikation humaner Angiogenese Method and means for modification of human angiogenesis |
| 02/10/2011 | CA2770149A1 Controlled release formulations of lipocalin muteins |
| 02/10/2011 | CA2770077A1 Formulations comprising linaclotide |
| 02/10/2011 | CA2769883A1 Use of melanocortins to treat dyslipidemia |
| 02/10/2011 | CA2769620A1 Orally administerable pharmaceutical preparation containing insulin |
| 02/10/2011 | CA2769347A1 Methods for treatment of pain |
| 02/10/2011 | CA2769262A1 Methods and compositions for treating trinucleotide repeat disorders |
| 02/10/2011 | CA2769001A1 Novel proteins |
| 02/10/2011 | CA2768999A1 Compositions and methods for treating gaucher disease |
| 02/10/2011 | CA2768990A1 Broad spectrum erbb ligand binding molecules and methods for preparing and using them |
| 02/09/2011 | EP2281885A1 Combination therapy for the treatment of ocular neovascular disorders |
| 02/09/2011 | EP2281869A2 Modulation of diacylglycerol acyltransferase 1 expression |
| 02/09/2011 | EP2281832A2 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 02/09/2011 | EP2281828A2 Compositions comprising modified erythropoietin |
| 02/09/2011 | EP2281624A1 Filtration method |